Blood test study to tell MS and NMOSD apart
Part of Brain & nervous system, Eyes & vision, Immune system & allergy clinical trials.
This study compares blood markers to help tell multiple sclerosis (MS) apart from a similar condition called neuromyelitis optica spectrum disorder (NMOSD). It may help find more accurate ways to diagnose these conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 50 years old
- You have been diagnosed with either multiple sclerosis (MS) or neuromyelitis optica spectrum disorder (NMOSD)
- You have not had a relapse (flare-up) in the last 3 months
- You are willing to give a blood sample and complete follow-up visits and MRI scans
- You are able to sign a consent form agreeing to participate
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at a specific gene change in people with MS, NMOSD, or MOGAD to see how common it is. By joining, you help researchers learn more about these conditions and possible future treatments.
This study measures blood markers (from a serum blood sample) to see how nerve and brain changes relate to MS disease activity and disability over time. It may help researchers better monitor MS, especially in people followed in the OFSEP program.
This trial uses brain MRI and eye imaging tests to study research markers in people with multiple sclerosis (MS) and related neurologic conditions. It may help researchers better understand these diseases and how they change over time.
This study looks for signs of “synapse damage” in multiple sclerosis using blood tests and brain imaging (MRI). The goal is to find biomarkers that may help better understand MS and how it changes over time.
This study is testing two new blood tests to see if they can better diagnose MOGAD, an inflammatory condition that affects the brain and spinal cord. If you or your doctor suspects MOGAD, this trial may help confirm the diagnosis.
This study follows people with NMOSD (a rare autoimmune disease affecting the brain and spinal cord) to learn more about the condition and how it affects patients over time. It involves regular check-ups and MRI scans, with the goal of improving future care and treatment.
Hear when a new MS (Multiple Sclerosis) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.